Advertisement
Product › Details
Vimovo®
Next higher product group | naproxen (INN) / esomeprazole magnesium | |
Status | 2007-09-07 development p3 planned | |
Organisation | Pozen Inc. (Nasdaq: POZN) | |
Record changed: 2023-07-10 |
Advertisement
More documents for analgesic / antirheumatic
- [1] Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen....
- [2] AlgoTherapeutix SAS. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes....
- [3] Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel....
- [4] Confo Therapeutics N.V.. (3/2/23). "Press Release: Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554". Ghent....
- [5] AlgoTherapeutix SAS. (9/1/22). "Press Release: AlgoTx Announces Initiation of Global Phase 2 Clinical Trial of ATX01 for the Relief of Pain in Chemotherapy-induced Peripheral Neuropathy in Adults". Suresnes....
- [6] Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg....
- [7] Grünenthal GmbH. (4/12/21). "Press Release: Grünenthal Acquires Mestex AG and Its Phase-III-ready Investigational Medicine MTX-071 for the Treatment of Pain Associated with Osteoarthritis of the Knee". Aachen....
- [8] Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde....
- [9] AlgoTherapeutix SAS. (11/24/20). "Press Release: AlgoTherapeutix Raises €12M to Take ATX01 into Clinical Development in Chemotherapy-induced Peripheral Neuropathy". Paris....
- [10] Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top